108 related articles for article (PubMed ID: 10100591)
1. The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells.
Merritt JE; Sullivan JA; Drew L; Khan A; Wilson K; Mulqueen M; Harris W; Bradshaw D; Hill CH; Rumsby M; Warr R
Cancer Chemother Pharmacol; 1999; 43(5):371-8. PubMed ID: 10100591
[TBL] [Abstract][Full Text] [Related]
2. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
[TBL] [Abstract][Full Text] [Related]
3. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
Drew L; Groome N; Warr JR; Rumsby MG
Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
[TBL] [Abstract][Full Text] [Related]
4. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
[TBL] [Abstract][Full Text] [Related]
5. Effects of MDR reversing agent combinations on the 3H-daunomycin accumulation in drug-sensitive and drug-resistant human cancer cells.
Moins N; Cayre A; Chevillard S; Maublant J; Verrelle P; Finat-Duclos F
Anticancer Res; 2000; 20(4):2617-23. PubMed ID: 10953334
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.
Christensen JG; LeBlanc GA
Cancer Res; 1996 Feb; 56(3):574-81. PubMed ID: 8564974
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
8. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
[TBL] [Abstract][Full Text] [Related]
9. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
10. Reversal of efflux of an anticancer drug in human drug-resistant breast cancer cells by inhibition of protein kinase Cα (PKCα) activity.
Kim CW; Asai D; Kang JH; Kishimura A; Mori T; Katayama Y
Tumour Biol; 2016 Feb; 37(2):1901-8. PubMed ID: 26323260
[TBL] [Abstract][Full Text] [Related]
11. Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro.
Eliason JF; Ramuz H; Yoshikubo T; Ishikawa T; Yamamoto T; Tsuruo T
Biochem Pharmacol; 1995 Jul; 50(2):187-96. PubMed ID: 7632162
[TBL] [Abstract][Full Text] [Related]
12. Effect of newly synthesized indole derivatives on multidrug resistance in human cancer cells.
Matsumoto T; Fujii R; Sugita M; Sumizawa T; Sakai S; Takahashi T; Sueda N; Furukawa T; Akiyama S; Nagata Y
Anticancer Drug Des; 1994 Jun; 9(3):251-61. PubMed ID: 7913322
[TBL] [Abstract][Full Text] [Related]
13. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.
Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S
Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378
[TBL] [Abstract][Full Text] [Related]
14. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.
Gupta KP; Ward NE; Gravitt KR; Bergman PJ; O'Brian CA
J Biol Chem; 1996 Jan; 271(4):2102-11. PubMed ID: 8567666
[TBL] [Abstract][Full Text] [Related]
15. The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C.
Han Z; Pantazis P; Lange TS; Wyche JH; Hendrickson EA
Cell Death Differ; 2000 Jun; 7(6):521-30. PubMed ID: 10822275
[TBL] [Abstract][Full Text] [Related]
16. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
17. The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance.
Gekeler V; Boer R; Ise W; Sanders KH; Schächtele C; Beck J
Biochem Biophys Res Commun; 1995 Jan; 206(1):119-26. PubMed ID: 7818510
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
Limtrakul P; Khantamat O; Pintha K
Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
[TBL] [Abstract][Full Text] [Related]
19. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
